A Children's Oncology Group Physics Committee Report on IROC Site Credentialing and Patient Case Review Results [0.03%]
儿童肿瘤学小组物理委员会关于IROC场地资质认定和患者病例审查结果的报告
Koren Smith,Paige Taylor,Chia-Ho Hua et al.
Koren Smith et al.
Purpose: The Imaging and Radiation Oncology Core (IROC) works with the Children's Oncology Group (COG) to provide institutional credentialing and patient radiotherapy plan review for sites that enroll patients on COG clin...
First Measurement: Proactively Sparing the Immune System During SBRT to Early-Stage Lung Cancer-A Randomized Phase II Study [0.03%]
主动在SBRT治疗早期肺癌时节省免疫系统的第一项测量结果：二期随机临床试验
Krishni Wijesooriya,Cam Nguyen,Mark R Conaway et al.
Krishni Wijesooriya et al.
Purpose: Minimizing Radiation-Induced-Lymphocyte-Kill (RILK), a key immune-suppressive effect of Radiation Therapy (RT) to augment tumor-specific immunity is timely and important. We assessed RT dose sparing to blood/immu...
Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp Trial [0.03%]
放射剂量体积指标与乳腺癌患者健康相关生活质量之间的关系（RadComp试验）
Jean L Wright,Kyunga Ko,Walter Kenworthy et al.
Jean L Wright et al.
Purpose: Relationships between radiation therapy (RT) dose to cardiac substructures and patient-reported outcomes, as assessed by health-related quality of life (HRQOL), remain unknown. We sought to: (1) compare RT dose t...
ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis [0.03%]
前列腺癌放疗联合内分泌治疗的系统评价和meta分析
Jamie S K Takayesu,Tian Xie,Jessica Aldous et al.
Jamie S K Takayesu et al.
Background and objective: There is substantially heterogeneous use of luteinizing hormone-releasing hormone analogues (LHRHa) with or without first-generation non-steroidal anti-androgens (NSAA, e.g. bicalutamide) during ...
Early Integrated Neuropsychological Care for Patients with Brain Metastases: A Randomized Controlled Trial (ATHENA Trial) [0.03%]
脑转移患者早期综合神经心理护理的随机对照研究（ ATHENA试验）
Haley K Perlow,Erica L Dawson,Yilun Sun et al.
Haley K Perlow et al.
Purpose: Decline of quality of life (QOL) and cognitive function is common for brain metastases patients receiving radiotherapy but there is currently no standard of care for addressing those symptoms. This phase 2 random...
A Phase 1 Trial of Dose-Escalated Hypofractionated Adaptive Radiation Therapy With Atezolizumab for Advanced Head and Neck Cancers [0.03%]
一项关于低分割自适应放射治疗联合阿特朱单抗治疗晚期头颈部肿瘤的I期临床试验
Musaddiq Awan,Sergey Tarima,Joseph Zenga et al.
Musaddiq Awan et al.
Purpose: To determine the maximum-tolerated dose (MTD) of dose-escalated hypofractionated adaptive radiation therapy with atezolizumab in patients with head and neck squamous cell carcinomas (HNSCCs) in a phase 1 trial. ...
Dose-escalated versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: 9-year Results of a Randomized Phase 2 Trial [0.03%]
术前放化疗剂量爬坡与标准治疗局部晚期直肠癌的随机II期临床试验：随访9年的结果分析
Haoyue Li,Ningyu Wang,Tongzhen Xu et al.
Haoyue Li et al.
Purpose: To compare the safety and efficacy of preoperative simultaneous integrated boost chemoradiotherapy (SIB-CRT) versus standard chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). ...
Ultra-hypofractionated whole breast irradiation in early-stage breast cancer: an Italian multi-centre observational study [0.03%]
早期乳腺癌超低分割全乳放疗：一项意大利多中心观察性研究
Isabella Palumbo,Anna Giulia Becchetti,Elisa D&#x;Angelo et al.
Isabella Palumbo et al.
Purpose: In patients who received breast-conserving surgery (BCS) for early-stage breast cancer, the present study assessed acute and short-term side effects and oncological outcomes after whole breast irradiation (WBI) w...
Jarad M Martin,Roel J H M Steenbakkers,David Schlect
Jarad M Martin
In Reply to Topkan et al [0.03%]
回复Topkan等作者
Laia Humbert-Vidan,Lisanne V van Dijk,Teresa Guerrero Urbano
Laia Humbert-Vidan